Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.

× No keyword cloud information.

15 in total

1. Results of radiation therapy combined with neoadjuvant hormonal therapy for stage III prostate cancer: comparison of two different definitions of PSA failure.

Authors: Michihide Mitsumori; Yoshihide Sasaki; Takashi Mizowaki; Kenji Takayama; Yasushi Nagata; Masahiro Hiraoka; Yoshiharu Negoro; Keisuke Sasai; Hidefumi Kinoshita; Toshiyuki Kamoto; Osamu Ogawa
Journal: Int J Clin Oncol Date: 2006-10 Impact factor: 3.402

Review 2. Clinical and Novel Biomarkers in the Management of Prostate Cancer.

Authors: Cristóbal Sanhueza; Manish Kohli
Journal: Curr Treat Options Oncol Date: 2018-02-08

3. Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer.

Authors: Philip J Saylor; Matthew R Smith
Journal: J Natl Compr Canc Netw Date: 2010-02 Impact factor: 11.908

4. Intermittent androgen deprivation therapy: redefining the standard of care?

Authors: Neal D Shore; E David Crawford
Journal: Rev Urol Date: 2010

5. Gonadotropin-releasing hormone agonists and the risks of type 2 diabetes and cardiovascular disease in men with prostate cancer.

Authors: Philip J Saylor; Nancy L Keating; Stephen J Freedland; Matthew R Smith
Journal: Drugs Date: 2011-02-12 Impact factor: 9.546

6. Androgen-deprivation therapy and risk for biliary disease in men with prostate cancer.

Authors: Philip J Saylor; Matthew R Smith; A James O'Malley; Nancy L Keating
Journal: Eur Urol Date: 2013-02-12 Impact factor: 20.096

Review 7. Metabolic complications of androgen deprivation therapy for prostate cancer.

Authors: Philip J Saylor; Matthew R Smith
Journal: J Urol Date: 2009-03-14 Impact factor: 7.450

8. Effective testosterone suppression for prostate cancer: is there a best castration therapy?

Authors: Leonard G Gomella
Journal: Rev Urol Date: 2009

9. Prospective study of changes in the metabolomic profiles of men during their first three months of androgen deprivation therapy for prostate cancer.

Authors: Philip J Saylor; Edward D Karoly; Matthew R Smith
Journal: Clin Cancer Res Date: 2012-05-15 Impact factor: 12.531

Review 10. Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.

Authors: Philip J Saylor; Nancy L Keating; Matthew R Smith
Journal: J Gen Intern Med Date: 2009-11 Impact factor: 5.128